Suchergebnisse - "Cavo, Michele"

PubPharm (742)

1

Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rodriguez-Otero, P. | Ailawadhi, S. | Arnulf, B. | +19

2

Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients

enthalten in: Cells | 2024

von Borsi, E. | Vigliotta, I. | Poletti, A. | +19

3

Real-life use of ropeg-interferon α2b in Polycythemia Vera: patient selection and clinical outcomes

enthalten in: ResearchSquare.com | 2024

von Palandri, F. | Branzanti, F. | Venturi, M. | +11

4

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System

enthalten in: JCO oncology practice | 2024

von Sparano, F. | Giesinger, J. | Gaidano, G. | +13

5

Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens : patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

enthalten in: The Lancet. Haematology | 2024

von Delforge, M. | Patel, K. | Eliason, L. | +15

ErratumIn: Lancet Haematol. 2024 Mar 12;:. - PMID 38490233

6

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 2024

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

7

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

enthalten in: Cancer | 2024

von Palandri, F. | Palumbo, G. | Benevolo, G. | +34

8

Belantamab mafodotin : an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

enthalten in: Haematologica | 2024

von Mateos, M. | Weisel, K. | Terpos, E. | +13

9

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features

enthalten in: Nature communications | 2024

von Terragna, C. | Poletti, A. | Solli, V. | +17

10

Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma : final overall survival analysis

enthalten in: Haematologica | 2024

von Richardson, P. | Perrot, A. | Miguel, J. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[75]